FzioMed Appoints James R. Peters to Board of Directors

SAN LUIS OBISPO, California – June 15, 2007 – FzioMed, Inc., a leader in surgical biomaterials, announced today the appointment of James R. Peters to the Company’s board of directors.

“Jim brings a wealth of knowledge and experience in the successful leadership of growing companies such as FzioMed,” said Ron Haynes, Chairman of FzioMed, Inc. “His understanding of our industry, and extensive work in matters related to financings and corporate development, will be of significant value as we expand our business.”

Mr. Peters retired in 2006 as partner in the audit practice of Ernst & Young where he served for thirty-five years. His experience includes service as coordinating partner for public and private corporate clients across a variety of industries including health sciences, and advisor to companies during IPO, merger and acquisition, and audit activities. Mr. Peters is a former faculty member of the Director’s Training Program at the Anderson School of Business at University of California, Los Angeles. He is also a former Advisory Board member for the Entrepreneurial Studies Program at the University of Southern California. Mr. Peters is a Certified Public Accountant and a member of the National Association of Corporate Directors. He serves on the boards of Natrol, Inc. (Nasdaq: NTOL) and ValueClick, Inc. (Nasdaq: VCLK) and has been a frequent speaker on the subjects of venture capital, entrepreneurship, and audit best practices.

About FzioMed

FzioMed is a privately held medical company developing and commercializing absorbable, surgical biomaterials based on the company’s patented science. FzioMed’s innovative polymer technology has uses in a variety of specialties including orthopedics, spine, gynecology, general surgery and aesthetic surgery. FzioMed products include Oxiplex/SP, the leading adhesion barrier for spine surgery currently marketed outside of the United States, Oxiplex/AP adhesion barrier for gynecologic and general surgery, and LaresseT cosmetic dermal filler. FzioMed products are for investigational use only in the U.S. Go to www.fziomed.com.

FzioMed®, Oxiplex® and Laresse® are registered trademarks of FzioMed, Inc.